Skip to main content

Anesthesia News (Page 2)

Liposomal Bupivacaine No Aid for Intracapsular Femoral Neck Fracture Outcomes

TUESDAY, Oct. 8, 2024 – Liposomal bupivacaine is not associated with significant improvement in postoperative pain or function or hospital length of stay following hip hemiarthroplasty for a femoral...

Preoperative IV Iron Treatment Better for Iron Deficiency Anemia

WEDNESDAY, Aug. 7, 2024 – For patients with preoperative iron deficiency anemia (IDA), intravenous (IV) iron treatment is associated with a significant reduction in 30-day postoperative mortality...

How Wildfire Smoke Could Be Harming Surgical Patients

TUESDAY, Aug. 6, 2024 – Wildfire smoke could interfere with the safety of surgeries, a new study warns. Inhaling the smoke could complicate the effects of anesthesia on surgical patients, and it...

Guidance Issued for Perioperative Care of Transgender, Gender-Diverse Patients

FRIDAY, Aug. 2, 2024 – In a guideline published online July 23 in Anaesthesia, recommendations for anesthetists are presented for the perioperative care of transgender and gender-diverse patients....

FDA Medwatch Alert: Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), Due To The Potential Presence of Visible Particulate

NEW YORK, NY., July 13, 2022 – Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100 mL Single Patient Use Glass...

FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia

DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) – Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres (ephedrine...

FDA Approves Byfavo (remimazolam injection) for the Induction and Maintenance of Procedural Sedation

Dublin, Ireland – 2 July 2020: Cosmo Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has approved Byfavo (remimazolam injection) for the induction and maintenance of p...

FDA Approves Emerphed (ephedrine sulfate) Ready-to-Use Injection for Hypotension During Anesthesia

Lincolnshire, Ill., April 21, 2020 — Nexus Pharmaceuticals announced today it has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, ...

FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia

PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA), submitted un...

FDA Medwatch Alert: General Anesthetic and Sedation Drugs: Drug Safety Communication - FDA Approves Label Changes for Use in Young Children

ISSUE: FDA has approved previously announced label changes regarding the use of general anesthetic and sedation medicines in children younger than 3 years. These changes include: A new Warning...

FDA Medwatch Alert: General Anesthetic and Sedation Drugs: Drug Safety Communication - New Warnings for Young Children and Pregnant Women

ISSUE: FDA is warning that repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third...

FDA Medwatch Alert: 0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira: Recall - Particulate Matter

ISSUE: Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of 0.25% Bupivacaine Hydrochloride Injection, USP (NDC: 0409-1159-02, Lot 59-064- DK, Expiry 1NOV2017) at the hospital/retail...

FDA Medwatch Alert: PharMEDium Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl): Recall - Presence of Glass Particulate Matter

[Posted 05/09/2016] Fresenius Kabi indicated in its recall notice that the presence of glass particulate matter in solution, if undetected and administered via the epidural route, could block drug...

Flamel Technologies Receives FDA Approval of Akovaz (ephedrine sulfate) for Surgical Hypotension

LYON, FRANCE--(Marketwired - May 2, 2016) - Flamel Technologies (NASDAQ: FLML) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's New Drug Application (NDA)...

FDA Medwatch Alert: Lidocaine HCl Injection, USP, 2 percent, by Hospira: Recall - Visible Particulates

ISSUE: Hospira, Inc. is recalling one lot of Lidocaine HCl Injection, USP, 2%, 20 mg per mL, 5 mL single-Dose Vial, Preservative-Free (NDC 0409-2066-05; Lot 25-550-DD, Expiry 1JAN2015) to the user...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Sedation, Light Sedation

Related drug support groups

fentanyl, lidocaine, ketamine